Upstate Active Clinical Trials
Study Title:CALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab (IND #7921, NSC #704865) to Gemcitabine, Cislpatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
What is the purpose of the study?The purpose of this study is to compare the effects of the combination of the chemotherapy drugs gemcitabine and cisplatin (chemotherapy) with the combination of gemcitabine, cisplatin and the experimental drug bevacizumab on transitional cell cancer.
Upstate Institutional Review Board (IRB) Number:235816
Patient Age Group:Adults
Principal Investigator:Bernard J Poiesz, MD
Who can I contact for more information?
Name: Wendy S Barry